Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways
- PMID: 37971580
- DOI: 10.1007/s12010-023-04755-9
Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways
Erratum in
-
Correction to: Ginkgo biloba Extract 50 (GBE50) Exerts Antifibrotic and Antioxidant Effects on Pulmonary Fibrosis in Mice by Regulating Nrf2 and TGF-β1/Smad Pathways.Appl Biochem Biotechnol. 2024 Sep;196(9):6575. doi: 10.1007/s12010-024-04852-3. Appl Biochem Biotechnol. 2024. PMID: 38421573 No abstract available.
Abstract
Background: Pulmonary fibrosis (PF) is a progressive lung disorder with a poor prognosis. GBE50 is a new standardized Ginkgo biloba extract that has been widely used in cardiovascular diseases. However, the protective mechanism of GBE50 against PF remains to be elucidated.
Methods: C57BL/6J mice were treated with bleomycin (Bleo) to induce PF in the presence or absence of GBE50. Protein content in bronchoalveolar lavage fluid (BALF) and wet weight/dry weight ratio were examined for analysis of pulmonary edema. Hematoxylin-eosin staining and Masson trichrome staining were used for histopathological observation of murine lung tissues. Ashcroft score was used for semi-quantitation of lung fibrosis degree. RT-qPCR was utilized for assessing mRNA levels of pro-fibrotic mediators in lung tissues. TUNEL staining was implemented for cell apoptosis assessment. The levels of oxidative stress- and inflammation-related markers were evaluated by corresponding commercial assay kits. Western blotting was used to evaluate levels of nuclear factor erythroid 2-related factor 2 (Nrf2) signaling- and transforming growth factor (TGF)-β1/SMAD signaling-related proteins.
Results: GBE50 alleviated lung injury and severity of fibrosis, reduced collagen deposition and cell apoptosis in lung tissues, and suppressed inflammatory response and oxidative stress injury in Bleo-stimulated PF mice. GBE50 activated Nrf2 signaling pathway and inactivated TGF-β1/SMAD signaling pathway in the lungs of Bleo-induced PF mice. Inhibition of Nrf2 signaling reversed GBE50-mediated inactivation of TGF-β1/SMAD signaling and attenuation of inflammation and oxidative stress in Bleo-induced PF mice.
Conclusion: GBE50 protects against Bleo-induced PF in mice by mitigating fibrosis, inflammation and oxidative stress via Nrf2 and TGF-β1/SMAD signaling pathways.
Keywords: Ginkgo biloba Extract 50; Bleomycin; Inflammation; Oxidative Stress; Pulmonary Fibrosis.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium.BMC Pulm Med. 2017 Apr 18;17(1):63. doi: 10.1186/s12890-017-0405-7. BMC Pulm Med. 2017. PMID: 28420366 Free PMC article.
-
Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 against cognitive impairment.J Ethnopharmacol. 2025 Jul 24;351:120059. doi: 10.1016/j.jep.2025.120059. Epub 2025 May 29. J Ethnopharmacol. 2025. PMID: 40449691
-
Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways.Cell Stress Chaperones. 2016 Mar;21(2):239-49. doi: 10.1007/s12192-015-0654-4. Epub 2015 Nov 17. Cell Stress Chaperones. 2016. PMID: 26577463 Free PMC article.
-
Discussion of the material basis for prevention and treatment of pulmonary fibrosis using naturally medicinal and edible homologous herbs based on the dynamic process of Nrf2, NF-κB and TGF-β in PF.Biomed Pharmacother. 2025 Apr;185:117911. doi: 10.1016/j.biopha.2025.117911. Epub 2025 Mar 15. Biomed Pharmacother. 2025. PMID: 40090283 Review.
-
Exploring the Antifibrotic Mechanisms of Ghrelin: Modulating TGF-β Signalling in Organ Fibrosis.Expert Rev Mol Med. 2024 Nov 21;27:e8. doi: 10.1017/erm.2024.38. Expert Rev Mol Med. 2024. PMID: 39569809 Free PMC article. Review.
Cited by
-
Circulating MicroRNAs in Idiopathic Pulmonary Fibrosis: A Narrative Review.Curr Issues Mol Biol. 2024 Dec 4;46(12):13746-13766. doi: 10.3390/cimb46120821. Curr Issues Mol Biol. 2024. PMID: 39727949 Free PMC article. Review.
-
Efficacy of ginkgo biloba extract in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis of randomized controlled trials.Front Pharmacol. 2025 Mar 5;16:1524505. doi: 10.3389/fphar.2025.1524505. eCollection 2025. Front Pharmacol. 2025. PMID: 40110130 Free PMC article. Review.
References
-
- Saleh, M., Fotook Kiaei, S. Z., & Kavianpour, M. (2022). Application of Wharton jelly-derived mesenchymal stem cells in patients with pulmonary fibrosis. Stem Cell Research & Therapy, 13(1), 71. - DOI
-
- Chen, I. C. (2022). Evaluation of Proteasome inhibitors in the treatment of Idiopathic Pulmonary Fibrosis. Cells, 11(9).
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical